跳至主要内容
临床试验/IRCT2015101411819N4
IRCT2015101411819N4已完成未知

Evaluation the Effect of Silymarin on Oxidative Stress Markers in Comparison with Placebo in ß-thalassemia Patients undergoing Iron

Mazandaran University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Patients with beta thalassemia major; History of iron chelation therapy for at least 2 years; Having relatively constant average dose of iron chelation during 3 months ago; Ferritin up to 1000 µg/L
  • Exclusion criteria: Change therapeutic regimen with iron chelation during the study (6 months)

排除标准

  • 未提供

研究者

相似试验